Results 241 to 250 of about 47,262 (255)
Some of the next articles are maybe not open access.

Sirtuins in mechanistic target of rapamycin complex 1 signaling

2021
J. Burillo   +5 more
openaire   +1 more source

Bevacizumab Impairs Morphine Analgesia through Tuberous Sclerosis Complex 1–Mechanistic Target of Rapamycin-Autophagy Dysregulation

Background: Bevacizumab is a widely used anti-VEGF-A therapy in oncology and ophthalmology, valued for its potent anti-angiogenic effects across cancer and ocular diseases. Beyond angiogenesis, growing evidence suggests that VEGF-A also contributes to neuronal homeostasis, including autophagy regulation, synaptic plasticity, and nociceptive ...
Cheng Li, Zhiwei Xu, Quan Ma, See PDF
openaire   +1 more source

Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex

Pediatric Neurology, 2020
Daniel Ebrahimi-Fakhari   +2 more
exaly  

Mechanistic Target of Rapamycin Complex 1 (mTORC1) Activity in an In Vitro Model of AKI

Journal of the American Society of Nephrology
Asha Rath, Sian E. Piret
openaire   +1 more source

Regulation of the mechanistic target of rapamycin complex 1 (mTORC1) - nuclear hormone receptor signaling by bile acids

Journal of Hepatology, 2017
T. Moustafa   +5 more
openaire   +1 more source

Mammalian Target of Rapamycin Signaling in Cardiac Physiology and Disease

Circulation Research, 2014
Sebastiano Sciarretta   +2 more
exaly  

Home - About - Disclaimer - Privacy